Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vita Life Sciences Limited ( (AU:VLS) ) has provided an update.
Vita Life Sciences Limited has announced a daily update on their ongoing on-market buy-back of ordinary fully paid securities. As of November 6, 2025, the company has bought back a total of 434,286 securities, with an additional 4,954 securities purchased on the previous day. This buy-back strategy indicates the company’s efforts to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the production and distribution of vitamins, supplements, and other health-related products. The company is listed on the Australian Securities Exchange (ASX) under the code VLS.
Average Trading Volume: 13,121
Technical Sentiment Signal: Buy
Current Market Cap: A$131.4M
For an in-depth examination of VLS stock, go to TipRanks’ Overview page.